Related Experiment Video
Updated: Aug 7, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study
Mohammad Rahmani1, Abdorreza Naser Moghadasi2, Shayan Shahi3
1Department of Neurology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Background:
Multiple sclerosis (MS) is an immune-mediated disease that has been related to several risk factors such as various viral infections. We carried out this study in order to establish a relationship between COVID-19 infection and MS severity.
Methods:
In a case-control study, we recruited patients with relapsing-remitting multiple sclerosis (RRMS). Patients were divided into two groups based on positive COVID-19 PCR at the end of the enrollment phase. Each patient was prospectively followed for 12 months. Demographical, clinical, and past medical history were collected during routine clinical practice. Assessments were performed every six months; MRI was performed at enrollment and 12 months later.
Results:
Three hundred and sixty-two patients participated in this study. MS patients with COVID-19 infection had significantly higher increases in the number of MRI lesions (p: 0.019, OR(CI): 6.37(1.54-26.34)) and EDSS scores (p: 0.017), but no difference was found in total annual relapses or relapse rates. COVID-19 infections were positively correlated with EDSS progression (p: 0.02) and the number of new MRI lesions (p: 0.004) and predicted the likelihood of the number of new MRI lesions by an odds of 5.92 (p: 0.018).
Conclusion:
COVID-19 may lead to higher disability scores in the RRMS population and is associated with developing new Gd-enhancing lesions in MRI imaging. However, no difference was observed between the groups regarding the number of relapses during follow-up.
Insights
COVID-19 infection may worsen multiple sclerosis (MS) severity, increasing disability scores and new MRI lesions in relapsing-remitting MS patients. Relapse rates remained unchanged during the follow-up period.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Multiple sclerosis (MS) is an immune-mediated condition linked to viral infections.
- The potential impact of COVID-19 on MS severity requires investigation.
Purpose of the Study:
- To determine the relationship between COVID-19 infection and the severity of multiple sclerosis.
- To assess the effect of COVID-19 on disease progression in patients with relapsing-remitting MS (RRMS).
Main Methods:
- A case-control study involving 362 patients with relapsing-remitting MS (RRMS).
- Patients were categorized based on COVID-19 PCR results.
- A 12-month prospective follow-up included clinical assessments and MRI scans at enrollment and 12 months.
Main Results:
- MS patients with COVID-19 showed significantly increased MRI lesions and EDSS scores.
- COVID-19 infection correlated positively with EDSS progression and new MRI lesions.
- COVID-19 predicted an increased likelihood of new MRI lesions (OR: 5.92).
Conclusions:
- COVID-19 may elevate disability scores in the RRMS population.
- COVID-19 is associated with the development of new gadolinium-enhancing lesions on MRI.
- No significant difference in relapse numbers was observed between COVID-19 positive and negative groups during follow-up.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bias in Epidemiological Studies
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Confounding in Epidemiological Studies
Causality in Epidemiology

